🟢 Solid Biosciences is trading 5% up

Solid Biosciences is trading at $6.51, up 5.17%, with no new company-specific announcement clearly explaining the October 28 move.

• Available search results identify an H.C. Wainwright Buy-rating reiteration and the company’s SGT-212 EU orphan designation, reported October 26–27; neither establishes a fresh catalyst for this session.
• The XBI rose 2.18% during the regular session. Solid Biosciences also rose 6.54% on October 27, extending its recent gains.